Abstract
Background
Soil-transmitted helminths (STH), Schistosoma spp. and Plasmodium falciparum are parasites of major public health importance and co-endemic in many sub-Saharan African countries. Management of these infections requires detection and treatment of infected people and evaluation of large-scale measures implemented. Diagnostic tools are available but their low sensitivity, especially for low intensity helminth infections, leaves room for improvement. Antibody serology could be a useful approach thanks to its potential to detect both current infection and past exposure.
Methodology
We evaluated total IgE responses and specific-IgG levels to 9 antigens from STH, 2 from Schistosoma spp., and 16 from P. falciparum, as potential markers of current infection in a population of children and adults from Southern Mozambique (N = 715). Antibody responses were measured by quantitative suspension array Luminex technology and their performance was evaluated by ROC curve analysis using microscopic and molecular detection of infections as reference.
Principal findings
IgG against the combination of EXP1, AMA1 and MSP2 (P. falciparum) in children and NIE (Strongyloides stercoralis) in adults and children had the highest accuracies (AUC = 0.942 and AUC = 0.872, respectively) as markers of current infection. IgG against the combination of MEA and Sm25 (Schistosoma spp.) were also reliable markers of current infection (AUC = 0.779). In addition, IgG seropositivity against 20 out of the 27 antigens in the panel differentiated the seropositive endemic population from the non-endemic population, suggesting a possible role as markers of exposure although sensitivity could not be assessed.
Conclusions
We provided evidence for the utility of antibody serology to detect current infection with parasites causing tropical diseases in endemic populations. In addition, most of the markers have potential good specificity as markers of exposure. We also showed the feasibility of measuring antibody serology with a platform that allows the integration of control and elimination programs for different pathogens.
Author summary
Parasitic worms and Plasmodium falciparum, the causal agent of malaria, are among the most relevant parasitic diseases of our time and efforts are under way for their control and, ultimately, elimination. An accurate diagnosis is relevant for case management, but also allows calculating the prevalence and evaluating the effectiveness of treatment and control measures. Unfortunately, current diagnostic methods for parasitic worms are not optimal and many infections remain undetected. As for P. falciparum, current diagnostic techniques are satisfactory but do not allow for ascertaining exposure, which is relevant for evaluating control measures. Here we investigated the utility of measuring antibodies to these parasites as a diagnostic method. Our results indicate that it is possible to detect current infection with parasitic worms and P. falciparum using antibody detection with a moderate to high accuracy. We also show that antibodies against the antigens in this study have potential as markers of exposure. Importantly, we used a platform that allows for the simultaneous detection of immunoglobulins to different parasites, which would be extremely useful as a tool to integrate control and elimination programs for several pathogens.
Introduction
Soil-transmitted helminths (STH) and Schistosoma spp. are amongst the most relevant neglected tropical diseases (NTDs), affecting 1.5 billion and 236.6 million people worldwide, respectively [1,2]. STH infections are caused by the parasitic worms Ascaris lumbricoides, Ancylostoma duodenale, Necator americanus, Trichuris trichiura and Strongyloides stercoralis. Malaria, caused by parasites of the genus Plasmodium, results in a high morbidity and mortality, with 241 million cases and 627,000 deaths in 2020 [3]. Both types of parasitic diseases overlap geographically, especially in areas of sub-Saharan Africa [4].
Microscopic observation of eggs or larvae is the recommended procedure for the diagnosis of STH and Schistosoma spp. infections. However, it requires well-trained personnel, is laborious and time consuming. It is also dependent upon the intermittent shedding of eggs or larvae, which requires collection of samples from different days for a correct detection [5–8]. On top of that, the impact of the low sensitivity of microscopy is exacerbated with lower intensity and prevalence of infections, which are likely after decades of Mass Drug Administration (MDA) to control these infections [9].
The diagnosis of Plasmodium spp. is commonly done by the detection of parasites, their genetic material or antigens in blood by microscopy, quantitative real-time polymerase chain reaction (qPCR) or rapid diagnostic tests (RDT), respectively [10]. These methods also face challenges, such as low parasitemia levels that remain undetected in the case of microscopy and RDT, the need for well-trained personnel for microscopy or the required equipment in low-income settings for qPCR.
Antibody serology could be a useful tool for detection of current infection but also exposure, which is not captured by any of the diagnostic methods above. For helminths, antibody serology has a particularly important role in the diagnosis of S. stercoralis infection, since conventional methods have a very low sensitivity and specific antibodies generally decrease 6 months after treatment, which helps detect current and recent infections [11–13]. In fact, antibody serology against the NIE antigen from S. stercoralis has been used to monitor MDA programs thanks to the comparatively rapid decay of antibodies after clearance of infection [14,15]. For other species, antibody serology is less common and not routinely implemented. However, there is evidence of their potential. For example, a study has shown that increased levels of immunoglobulin G4 (IgG4) against the Ascaris spp. antigen AsHb reflected recent exposure to the parasite [16], and another study reported moderate accuracy of IgG against N. americanus proteins in detecting current infection [17]. In the case of Schistosoma spp., there are commercial kits that might be useful for the diagnosis of imported schistosomiasis in individuals from non-endemic or low-endemic areas, while in high- to moderate- endemic areas they have proven limited utility [18,19]. For malaria, serology has mostly been used to measure exposure and determine malaria endemicity, transmission intensity and to monitor interventions [20,21]. In fact, this ability of antibodies to capture exposure even in the absence of current infection has been exploited as an useful tool in control and elimination programs for other infections to monitor changes in transmission, such as the elimination programs of lymphatic filariasis [22], onchocerciasis [23] and trachoma [24].
Identification of patent helminth infection and Plasmodium spp. parasitemia by serology can be challenging, particularly in endemic areas, due to the generally long-lasting antibody responses and repeated exposure [21,25]. However, it might be useful in patients who have been in endemic areas for the first time, for less prevalent infections, or in cases of very low parasite burden [26,27], for which highly sensitive diagnostic tests are required.
Increasing evidence indicates that the potent immunomodulatory effects of helminths might have effects on the immune response to P. falciparum [4]. Moreover, we have recently shown that this interaction might be bidirectional, since it was observed that exposure to or co-infection with helminths and P. falciparum was associated with an increase in antibody responses to antigens from both pathogens [28]. Given the reported bidirectional impact on the immune responses to both parasitic infections, it is relevant to study antibody serological diagnostic methods in a context where co-infections might occur and affect the accuracy of the diagnosis. In this study we have evaluated total IgE and antigen-specific IgGs against a wide panel of antigens from helminths (STH, Schistosoma spp.) and P. falciparum parasitic infections as potential markers of current infection.
Methods
Ethics statement
The study was carried out according to the principles of the Declaration of Helsinki. Written informed consent from individuals older than 18 years old who were willing to participate was obtained. In the case individuals younger than 18 years old, their parents or guardians provided a written informed consent. Additionally, participants from ages 15 to 17 also gave written informed assent. For illiterate individuals, written informed consent was conducted in presence of a literate witness independent from the study. Samples analyzed in this study received ethical clearance for immunological evaluation and/or inclusion as controls in immunoassays. The protocols and informed consent forms were approved by the Institutional Review Board at Hospital Clínic in Barcelona (Ref.: CEIC-7455) and the National Bioethics Committee for Health in Mozambique (Ref.: 517/CNBS/17).
Study samples
Stool, urine, and blood samples were collected and analyzed from children (5–15 years old) (N = 363) and adults (>15 years old) (N = 352) from Manhiça district, a malaria [29] and helminth [30] endemic area in Maputo province, Southern Mozambique (N = 715). Biological samples were collected in the context of a community-based, case-cohort study (MARS). MARS aimed to design and implement a surveillance platform to identify and characterize genotypically and phenotypically anthelmintic resistance in Manhiça district [30].
Briefly, collection of samples took place between December 2017 and December 2018 and followed a grid-sampling methodology, whereby households in a defined area from Manhiça district were randomly selected and the closest to the centroid was chosen [30]. A field worker visited the household and invited two people to participate, one between the ages of 5 and 15 and the other over 15 years old. The participants in the study were censed in the Manhiça Health Research Centre (CISM) Demographic Surveillance System and had not taken anthelmintics at any time during the previous 30 days [30]. No information regarding symptomatology was collected. The samples analyzed here are from the initial cross-sectional survey performed at the beginning of the study.
Initially, the study recruited 819 individuals. The final sample size for this analysis was 715. One-hundred and three samples were excluded from the analysis because they were either not shipped to Barcelona (Spain) (N = 5) or due to study withdrawal (N = 25), sample insufficiency (N = 4) or incorrect serum elution (N = 69).
Serum samples from Spanish adult donors were used as unexposed negative controls (NC) (N = 50) in the serological assays. They represent individuals from a non-endemic area who had never travelled to any countries endemic for the infections addressed in the study.
Study area and evidence of prevalence of parasitic infections
As reported by national health ministries to the Expanded Special Project for Elimination of Neglected Tropical Diseases (ESPEN) through World Health Organization (WHO) reporting processes, the endemicity of STH and schistosomiasis prior to sample collection in the region were moderate (20–49.9% and 10–49.9% prevalence, respectively), despite receiving MDA (PZQ+ALB/MBD) [31]. However, differences at district or smaller areas are probable. In this regard, a report from a hospital-based, cross-sectional study performed in Manhiça district between 2015 and 2016 informed about the prevalence of hookworm, T. trichiura, A. lumbricoides and S. stercoralis in children between 2- and 10-years old attending the hospital and reported a percentage of infection of 3% for N. americanus, 0.5% for A. duodenale, 4% for T. trichiura, 7.4% for A. lumbricoides and 8.6% for S. stercoralis [32]. Nonetheless, that study was biased toward sick and symptomatic children and is not representative of the whole population. In addition, a previous report from the MARS study provided the quantitative results by Kato-Katz and informed that none of the infections in the study were of high intensity and only 1.8% had a moderate intensity infection detected by single Kato-Katz from one stool, suggesting that this is a low-intensity infection area [30]. Regarding P. falciparum, there was a trend for increased incidence of malaria from 2010 to 2016 in Mozambique and the country appeared as the 4th contributing country to global malaria cases in 2016, accounting for 4% of the global toll [33]. In the region of Manhiça district, the most recent indicators of P. falciparum are from 2013 in a well-known high transmission area also included in this study, where the increasing trend observed at national level was also observed [34].
Detection of helminth and P. falciparum infections by the reference methods
Helminth infections were detected by microscopic and molecular diagnosis at the Manhiça Health Research Centre (CISM) (Mozambique) and Leiden University Medical Center (The Netherlands), respectively.
Microscopic diagnosis of N. americanus, A. duodenale, T. trichiura, A. lumbricoides and S. mansoni was performed by search of eggs in two stool samples from two consecutive days using duplicate Kato-Katz thick smear technique and Telemann technique [35,36]. S. stercoralis was detected in two stool samples from two consecutive days using the Telemann technique [36]. S. haematobium infection was detected by microscopy after urine filtration [35]. Individuals were considered to be positive for helminth infection by copromicroscopy if they had a positive result in at least one of the stool samples [30].
Molecular diagnosis was also performed in one stool sample per participant by multiplex semi-qPCR, as described in detail elsewhere [30]. Two different multiplex detection panels were used; panel 1 targeted Schistosoma spp. and T. trichiura, and panel 2 targeted A. duodenale, N. americanus, A. lumbricoides and S. stercoralis. Of note, qPCR to detect helminth infections was not performed in 25 out of the 715 samples from the endemic population.
P. falciparum infection was determined at the Barcelona Institute for Global Health (ISGlobal) (Spain) by 18S ribosomal RNA gene detection through qPCR from dried blood spot (DBS) samples as previously described [28].
Serological assays
A detailed explanation of the antigen panel and serum elution procedure from DBS used for this analysis is described in Santano et al. 2021 [28]. Eluted serum was used to measure total IgE and antigen-specific IgG by quantitative suspension array technology (qSAT) using xMAP Luminex technology against a panel of 27 antigens: 16 from P. falciparum (α-gal, CelTOS, SSP2, LSA1, EXP1, AMA1, EBA175, MSP1 block 2, MSP142, MSP2, MSP3, MSP5, P41, RH1, RH5 and PTRAMP) and 11 from helminths (hookworm [NaGST1, NaAPR1, NaSAA2, AyCp2], Trichuris spp. [TmWAP, Tm16], Ascaris spp. [As16, As37], S. stercoralis [NIE] and Schistosoma spp. [MEA, Sm25]). The antigens and a capture anti-human IgE (Mouse anti-Human IgE Fc; ref. ab99834, Abcam PLC, Cambridge, UK) were coupled to magnetic MagPlex 6.5μm COOH-microspheres (Luminex Corporation, Austin, USA). The antigen-coupled beads were used in multiplex while the anti-human IgE-coupled beads were used in singleplex. Coupled beads were incubated with test and control serum samples, in black 96-well μClear flat bottom plates at 4°C overnight (ON) in a shaker at 600 rpm. For the antigen-specific IgG quantification we assayed the samples at 1:100 and 1:2000 dilutions, and for total IgE quantification we assayed the samples at 1:50 dilution. After the ON incubation beads were washed three times with PBS-0.05% Tween20, using a manual magnetic washer platform (ref. 40–285, Bio-Rad, Hercules, USA), and the biotinylated secondary anti-human IgG (ref. B1140-1ML, MilliporeSigma, St. Louis, USA)] and anti-human IgE (ref. A18803, Invitrogen, Waltham, USA) antibodies were added at 1:1250 and 1:100 dilutions, respectively, and incubated for 45 min at room temperature (RT) shaking at 600 rpm. Then, beads were washed three times and streptavidin-R-phycoerythrin (ref. 42250-1ML, MilliporeSigma, St. Louis, USA) was added at 1:1000 dilution and incubated at RT for 30 min at 600 rpm. Finally, beads were washed, resuspended, and at least 50 beads per analyte and sample were acquired in a FlexMap 3D xMAP instrument (Luminex Corporation, Austin, USA). Crude median fluorescent intensities (MFI) and background fluorescence from blank wells were exported using the xPONENT software v.4.3 (Luminex Corporation, Austin, USA).
Data analysis
To determine the seropositivity and perform the statistical analysis, normalized and dilution corrected antibody data were log10-transformed. Detailed information on the processing of data can be found in Santano et al. 2021 [28].
The receiver operating characteristic (ROC) curves and their corresponding areas under the curve (AUC) for each antibody response were built with the R CRAN package pROC [37] using the log10-transformed MFIs as predictor and the microscopic, molecular or combination of both diagnoses as response variable. Since antibodies are acquired over time [28], we also performed the analysis stratified by age group (children and adults). In addition, to eliminate the possible interference of helminths and P. falciparum co-infections with the performance of the assessed markers, we estimated additional ROC curves and AUC analyses where the log10 MFIs from samples with only one infection (cases) or no infection (controls) diagnosed by the corresponding method were used as predictors, and the microscopic, molecular or combination of both diagnoses as response variables. Finally, we also evaluated the performance of combined antibody serological markers for those parasites for which more than one antigen was available. To do so, we built logistic regression models using the R function “glm” with the combination of log10-transformed MFIs as predictor variable and the microscopic, molecular or combination of both diagnoses as response variable. The predicted values fitted by those models were then used to build the ROC curves and calculate the corresponding AUCs. For those parasites with only two antigens in the panel (Ascaris spp., Trichuris spp. and Schistosoma spp.), we performed the analysis with the combination of those two antigen-specific IgG levels. For hookworm we performed all the possible combinations and selected the one that gave the best AUC with the lowest number of predictors. In the case of P. falciparum antigens, we followed the same strategy but we included only the top performers to calculate the combinations, whether for the whole population (10 top performers, 1013 models) or stratified by age (adults: 10 top performers, 1013 models; children: 3 top performers, 4 models). For the analysis of antigen-specific IgG, MFI data from the 715 samples from endemic individuals and the 50 samples from Spanish donors were used. In the case of total IgE only MFI data from endemic individuals were used, since there are other IgE-inducing pathologies, such us allergy, which are prevalent in Spain and render these samples not useful as negative controls.
Five seropositivity cutoffs were compared to evidence the options that can be used in scenarios requiring prioritization of specificity, sensitivity or a more balanced performance, and to contrast the performance of cutoffs calculated with data from non-endemic or endemic populations. The Expectation-Maximization (EM) cutoff was estimated using Gaussian Mixture Models for each antigen-specific IgG and total IgE in the study population. Two models, estimated by the EM algorithm, were fitted assuming either equal or unequal variances, and each of those two models were built with two clusters for classification, which were meant to represent the distribution of seropositive and seronegative samples in the endemic population. For each antigen, classification of samples was done using the model showing the optimal Bayesian Information Criterion (BIC). The models were fitted using the R CRAN package mclust [38]. The NC cutoff was calculated as the mean plus 3 standard deviations of the log10-transformed MFIs from the Spanish donors for each antigen-specific IgG. Finally, the ROC curves were used to generate three different cutoffs. The first one prioritized a minimum specificity of 95% (95SP) and the maximum sensitivity within the possible cutoffs. The second one prioritized a minimum sensitivity of 95% (95SE) and the maximum specificity within the possible cutoffs. The third one prioritized the maximum Youden’s index (YI), which is the cutoff with the maximum distance from the line of identity.
We then evaluated whether having an infection with any of the parasites detected in the study had an effect on the specific IgG levels and therefore influenced the false positive or false negative rates for a given seropositivity cutoff. To do so, for each antigen in the panel we selected the individuals who had a negative diagnosis for the corresponding species (i.e.: for NIE [from S. stercoralis] we selected all individuals with a negative S. stercoralis diagnosis). Among these individuals, we selected those who had only one single infection (to avoid interferences from co-infections) or no infection diagnosed. Finally, we compared the antibody levels for each species to the levels of those with no infection diagnosed. Pairwise comparisons were done by Wilcoxon rank-sum test and Holm adjustment for multiple testing. P values < 0.05 were considered statistically significant.
All data processing and statistical analyses were performed using the statistical software R version 4.0.3. R CRAN packages used to manage data, generate tables and plots were tidyverse [39], ggpubr [40], ggbeeswarm [41] and UpSetR [42].
Results
Prevalence of infections among study participants
When considering both microscopic and qPCR diagnoses, the most prevalent helminth infection among study participants was hookworm (28%), followed by T. trichiura (14.41%), Schistosoma spp. (12.03%), S. stercoralis (10.35%) and A. lumbricoides (7.41%) (S1 Table). T. trichiura was more frequent among children while hookworm, S. stercoralis and Schistosoma spp. were more common among adults, and A. lumbricoides had a similar distribution across age groups. The percentage of the population of study with a P. falciparum infection detected by qPCR was 9.93%, and it was slightly more common among adults.
Polyparasitism was less frequent than single infections, with a percentage among infected people of 23.93% for helminth infections detected by microscopy, 30.81% when detected by qPCR and 33.41% when detected by either of the methods (Fig 1). In general, the most common coinfections were with hookworm given that it was the most frequent parasite.
Fig 1. Frequencies of helminth and Plasmodium falciparum single infections and polyparasitism in the study cohort.
Rows represent the number of infections by parasite (sets) and columns represent the frequency of single infections and coinfections (intersections) when helminth infection was detected by microscopy (A), qPCR (B) or the combination of both (C). In all cases, infection of P. falciparum was detected by qPCR. In the case of helminth detection by qPCR, there were 25 samples for which helminth qPCR was not available. Filled dots show which set is part of an intersection and when more than one set is involved, they are connected by lines. At the bottom, the sample size and percentage of single infections of polyparasitism with respect to the total of infected individuals are indicated.
Antibody serological markers of current helminth infection
A good serological marker of current infection should be able to distinguish those currently infected from those not infected although previously exposed. The ROC curves analyses and their corresponding AUC showed that IgG levels against most of the helminth antigens in the panel had a low (0.50 ≤ AUC > 0.70) or null accuracy (0.50 < AUC) [43] in detecting current helminth infection as defined by microscopy, qPCR or their combination (Fig 2A and S2 Table). However, IgG levels against some antigens showed a moderate accuracy (0.70 ≤ AUC > 0.90) in detecting current infection. Namely, NIE from S. stercoralis had an AUC = 0.872 using qPCR as a reference, while the AUCs using microscopy or both techniques were slightly lower (Figs 2A and 3). However, the number of S. stercoralis infections detected by microscopy was very low (N = 8), probably giving unreliable results. MEA and Sm25 from Schistosoma spp. had AUC = 0.746 and AUC = 0.741, respectively, using S. mansoni microscopy data as reference (Figs 2A and 3). Sm25 also showed moderate AUC when using Schistosoma spp. microscopy (AUC = 0.721), Schistosoma spp. qPCR (AUC = 0.712) or S. haematobium microscopy (AUC = 0.711) as references (Figs 2A and 3). The remaining cases had all AUC < 0.700 (Fig 2A and S2 Table). When all specific-IgG responses were combined for helminths with more than one antigen in the panel, we observed a slight improvement in the AUCs for Schistosoma spp. (S1 Fig) but no improvement for the rest.
Fig 2.
Areas under the curve from receiver operating characteristic curve analysis for helminth-specific IgG levels in the whole population (A) or stratified by age (B). Dashed lines represent the accuracy thresholds: null if AUC < 0.5, low if 0.5 ≤ AUC > 0.7, moderate if 0.7 ≤ AUC > 0.9 and high if AUC ≥ 0.9. AUC: Area Under the Curve; CI: Confidence Interval; M: Microscopy; P: qPCR; MP: Microscopy and qPCR combined. Asc: Ascaris spp.; Hoo: Hookworm; Tri: Trichuris spp.; Str: Strongyloides stercoralis; Sch: Schistosoma spp.; Sh: Schistosoma haematobium; Sm: Schistosoma mansoni. Complementary information for this figure can be found in S2 Table.
Fig 3. Receiver operating characteristic curves and their corresponding areas under the curve from the best performing IgG responses in detecting current helminths infection.
IgG responses (log10-transformed median fluorescence intensity [MFI] levels) against S. stercoralis (NIE) and Schistosoma spp. (MEA and Sm25) antigens in serum samples from 715 endemic individuals and 50 Spanish donors were used as predictor variables. Microscopic (M), qPCR (P) or the combination of both (MP) diagnoses were used as response variables. S spp.: Schistosoma spp.; Sh: Schistosoma haematobium; Sm: Schistosoma mansoni. AUC: Area Under the Curve.
After stratifying by the age group, the performance for NIE improved for adults when using microscopy as reference, but the cases were very few (N = 5) to generate reliable results (Fig 2B and S2 Table). On the other hand, the results using qPCR or qPCR combined with microscopy as references were only slightly better in children compared to adults or equal, respectively, but lower than before the age stratification (Fig 2B and S2 Table). As for Schistosoma spp., moderate and high AUC values were higher than in the non-stratified analysis, but the children (N < 5) and adult (N = 11) sample size after stratification was much reduced in those cases (Fig 2B and S2 Table).
Finally, the analysis removing all individuals with other infections besides the one being evaluated (for cases) and any infection at all (for controls), revealed that the AUC reached excellent levels for NIE (AUC > 0.9), although the sample size of cases by microscopy was very small (N = 3) (S4 Table).
Total, not antigen-specific IgE levels were also evaluated as a proxy of current helminth infection. They showed low accuracy for most infections, but moderate accuracy in detecting infections by Schistosoma spp. (AUC = 0.715), S. mansoni (AUC = 0.728), S. haematobium (AUC = 0.712) and hookworm (AUC = 0.700) as defined by microscopy (Figs 4A and 5 and S2 Table). When infections were detected by qPCR or qPCR combined with microscopy, AUCs were slightly lower. Total IgE also had a moderate accuracy for S. stercoralis (AUC = 0.722), but the sample size of cases diagnosed by microscopy was very small (N = 8, Fig 4A and S2 Table). After stratifying by age group, the AUCs for hookworm and Schistosoma spp. infections either did not improve or were only slightly better in children than adults (Fig 4B and S2 Table). Finally, the analysis removing all individuals with other infections besides the one being evaluated (for cases) or any infection at all (for controls), showed that total IgE had an AUC = 0.707 using microscopic diagnosis of hookworm as reference (S4 Table). Total IgE using microscopic diagnosis of S. mansoni as reference had an AUC = 0.741, but the sample size of controls was small (S4 Table).
Fig 4. Areas under the curve from receiver operating characteristic curve analysis for total IgE.
The performance of total IgE levels to detect helminth or Plasmodium falciparum infections in the whole population is shown in A and stratified by age in B. Dashed lines represent the accuracy thresholds: null if AUC < 0.5, low if 0.5 ≤ AUC > 0.7, moderate if 0.7 ≤ AUC > 0.9 and high if AUC ≥ 0.9. AUC: Area Under the Curve; CI: Confidence Interval; M: Microscopy; P: qPCR; MP: Microscopy and qPCR combined. Asc: Ascaris spp.; Hoo: Hookworm; Tri: Trichuris spp.; Str: Strongyloides stercoralis; Sch: Schistosoma spp. Hel: Helminths; Pf: Plasmodium falciparum.; Sh: Schistosoma haematobium; Sm: Schistosoma mansoni. Complementary information for this figure can be found in S2 and S3 Tables.
Fig 5. Receiver operating characteristic curves and their corresponding areas under the curve from the best performing total IgE responses in detecting current hookworm and Schistosoma spp. infection.
Total IgE responses (log10-transformed median fluorescence intensity levels) in serum samples from 715 endemic individuals were used as predictor variable. Microscopic (M), qPCR (P) or the combination of both (MP) diagnoses for hookworm and Schistosoma spp. were used as response variables. DX: diagnosis; S spp.: Schistosoma spp.; Sh: Schistosoma haematobium; Sm: Schistosoma mansoni; AUC: Area Under the Curve.
Antibody serological markers of current P. falciparum infection
IgG levels against most P. falciparum antigens, including MSP2 (AUC = 0.826), EXP1 (AUC = 0.798), MSP142 (AUC = 0.790), AMA1 (AUC = 0.785), MSP5 (AUC = 0.784), MSP3 (AUC = 0.772), PTRAMP (AUC = 0.735), RH1 (AUC = 0.726), EBA175 (AUC = 0.721) and LSA1 (AUC = 0.707) showed a moderate accuracy in detecting P. falciparum infection as defined by qPCR diagnosis (Fig 6A and S3 Table). IgG levels against the remaining P. falciparum antigens of the panel had low accuracy in detecting current P. falciparum infection (S3 Table). The top performers mentioned above were used to calculate all possible combinations and build the regression models. The combination that yielded the highest AUC with the simplest formula was AMA1 + EBA175 + MSP142 + MSP2 + MSP3 + MSP5 with an AUC = 0.853 (S1 Fig), only slightly better than the best performer MSP2.
Fig 6. Receiver operating characteristic curves and their corresponding areas under the curve from the best performing IgG responses in detecting current Plasmodium falciparum infection.
A. IgG responses (log10-transformed median fluorescence intensity [MFI] levels) against LSA1, EXP1, AMA1, EBA175, MSP142, MSP2, MSP3, MSP5, Rh1 and PTRAMP in serum samples from 715 endemic individuals and 50 Spanish donors were used as predictor variables and qPCR results as response variable. B. IgG responses (log10-transformed MFI levels) against EXP1, AMA1 and MSP2 in serum samples from children (N = 363) and adults (N = 352) were used as predictor variables and qPCR results were used as response variable. In each age group, antibody levels in samples from the 50 Spanish donors were used as negative controls. AUC: Area Under the Curve.
After stratifying by age group, AUC values improved for most of the antigens in children except for CelTOS, LSA1, MSP1 block 2 MAD20, RH1 and PTRAMP, for which the values were higher in adults (S3 Table). Remarkably, AUC values in children reached high levels (>0.9) for EXP1, AMA1 and MSP2 (Fig 6B and S3 Table). These top performers were used to calculate all possible combinations for the analysis in the children group, while CelTOS, LSA1, EXP1, MSP1 block 2, MSP142, MSP2, MSP3, MSP5, RH1 and PTRAMP were used for the adult group. The best combinations and their corresponding AUCs were: EXP1 + AMA1 + MSP2 with AUC = 0.942 for children (S1 Fig) and LSA1 + EXP1 + MSP142 + MSP2 + MSP3 + MSP5 + PTRAMP with AUC = 0.848 for adults (S1 Fig). In addition, when all individuals with helminth infections were removed from the analysis, the AUC values slightly improved for most antigens with moderate AUC in the analysis including adults and children together (S4 Table).
Alternative seropositivity cutoffs for current infection
To further explore alternative ways to detect current infection, we investigated other possible seropositivity cutoffs extracted from the ROC analysis that could serve in different scenarios that would require prioritization of specificity, sensitivity or both. We also explored the ability of the EM cutoff to detect current infection. Finally, we assessed the performance of the classical cutoff based on the IgG levels measured in samples from a naïve population, in this case the Spanish donors, calculated as the mean plus 3 standard deviations. The results are summarized in Fig 7 for the top performer antigens of the panel (NIE, MEA, Sm25, EXP1, AMA1 and MSP2) and for the rest of the antigens in S2 and S3 Figs and S5 Table, where the specificity and sensitivity of each cutoff method are indicated.
Fig 7. Helminth and Plasmodium falciparum antigen-specific IgG levels in non-endemic and endemic populations and seropositivity cutoffs calculated by different methods.
Antibody levels are presented as the log10-transformed median fluorescence intensity (MFI) of IgG against Strongyloides stercoralis (NIE), Schistosoma spp. (Sm25 and MEA) and P. falciparum (EXP1, AMA1 and MSP2) antigens. In the endemic population, filled dots highlight individuals with a helminth infection with the corresponding parasite for each antigen detected by microscopy and/or qPCR in the case of helminths and qPCR in the case of P. falciparum. The boxplots represent the median (bold line), the mean (black diamond), the first and third quartiles (box) and the largest and smallest values within 1.5 times the interquartile range (whiskers). Data beyond the end of the whiskers are outliers. Cutoff95SE: cutoff prioritizing a minimum sensitivity of 95%; Cutoff95SP: cutoff prioritizing a minimum specificity of 95%; CutoffYI: cutoff corresponding to the maximum Youden’s Index; CutoffEM: cutoff defined by the Expectation-Maximization algorithm; CutoffNC: cutoff calculated as mean + 3*standard deviations of the log10-transformed MFI levels from the non-endemic population. NE: Non-Endemic (N = 50), E: Endemic (N = 715). The rest of the antigens are in S2 and S3 Figs.
For NIE specially, the EM cutoff provided a good trade-off between specificity (~80%) and sensitivity (~80%) and it overlapped with the Youden’s Index cutoff (Fig 7 and S5 Table). For Sm25, when taking Schistosoma spp. infection as a reference defined by the combination of microscopy and qPCR, the EM cutoff also overlapped with the Youden’s Index cutoff but the sensitivity was compromised (~70%) by the large variability in the NC, as reflected by the elevated NC cutoff (Fig 7 and S5 Table). On the other hand, responses against MEA induced less variability in the NC, but the EM and Youden’s Index cutoffs did not overlap. In this case, the EM cutoff had a 28% sensitivity and 82% specificity, while the Youden’s Index cutoff had a 70% sensitivity and 56% specificity (Fig 7 and S5 Table) when taking Schistosoma spp. infection as a reference defined by the combination of microscopy and qPCR.
For EXP1, AMA1 and MSP2, all cutoffs, except the cutoff that prioritized specificity, had sensitivity values above 94% and specificity values between 30–55% with the exception of the Youden’s Index cutoff for MSP2 (~75% sensitivity and specificity) (Fig 7 and S5 Table).
Effect of other infections on parasite-specific antibody levels
We assessed the effect of each single infection analyzed on the antigen-specific IgG levels of the top performer antigens of the panel (NIE, MEA, Sm25, EXP1, AMA1 and MSP2) to evaluate if other infections could be associated with false seropositive responses. S. stercoralis single infection was associated with statistically significantly higher IgG levels to MEA, Sm25, EXP1, AMA1 and MSP2 compared to no infections (Fig 8). In addition, Schistosoma spp. single infection was associated with statistically significantly higher IgG levels to NIE, AMA1 and MSP2 compared to no infections (Fig 8). Conversely, infection with T. trichiura was associated with statistically significantly lower IgG levels to MEA, EXP1, AMA1 and MSP2 compared to those with no infections (Fig 8). The same patterns for S. stercoralis, Schistosoma spp. and T. trichiura infections were observed among the rest of the antigens of the panel (S4 and S5 Figs). We also evaluated how the proposed cutoffs would classify those individuals with increased antibody levels that have a negative diagnosis for the corresponding parasite to the antigen. Taking NIE as an example only the 95% specificity cutoff classifies as seronegative most of those individuals that are S. stercoralis negative but Schistosoma spp. positive (Fig 8). However, this cutoff has a very reduced sensitivity (Fig 8 and S5 Table). This applies also to the rest of the top performing antigens, although in the case of Sm25, the NC cutoff has the highest specificity (Fig 8 and S5 Table).
Fig 8. Effect of single infections on IgG levels to other infections.
Only individuals with single infections or no infections at all detected by the combination of microscopy and qPCR are shown. Antibody levels are presented as the log10-transformed median fluorescence intensity (MFI) of IgG against Strongyloides stercoralis (NIE), Schistosoma spp. (Sm25 and MEA) and P. falciparum (EXP1, AMA1 and MSP2) antigens. For each antigen, antibody levels for each species were compared to the levels of those with no infection and the corresponding species to the antigen was shown as a reference. Statistical comparison between groups was performed by Wilcoxon rank-sum test and the adjusted P values by the Holm approach are shown. Statistically significant P values are highlighted in bold. The sample size of each group is shown below each boxplot. The boxplots represent the median (bold line), the mean (black diamond), the first and third quartiles (box) and the largest and smallest values within 1.5 times the interquartile range (whiskers). Data beyond the end of the whiskers are outliers. Cutoff95SE: cutoff prioritizing a minimum sensitivity of 95%; Cutoff95SP: cutoff prioritizing a minimum specificity of 95%; CutoffYI: cutoff corresponding to the maximum Youden’s Index; CutoffEM: cutoff defined by the Expectation-Maximization algorithm; CutoffNC: cutoff calculated as mean + 3*standard deviations of the log10-transformed MFI levels from the non-endemic population. Asc: Ascaris spp.; Hoo: Hookworm; Tri: Trichuris spp.; Str: Strongyloides stercoralis; Sch: Schistosoma spp. Hel: Helminths; Pf: Plasmodium falciparum. The rest of the antigens are in S4 and S5 Figs.
Performance of antibodies as markers of exposure
Besides current infection, in some contexts it may be useful to be able to detect and quantify exposure. The cross-sectional design of this study did not allow for evaluating recent versus past exposure. Therefore, we explored the ability of serology to differentiate individuals from a non-endemic area (NC) from likely exposed individuals from an endemic area. To do so, we took as reference the EM cutoff, which splits the Mozambican individuals into two populations (seronegative and seropositive) based on the distribution of antibody levels to each antigen. We considered as potential good markers of exposure those antibodies that had a high specificity, i.e., those for which levels in the non-endemic population had little or no overlap with levels in the seropositive individuals from the endemic population, as defined by the EM cutoff.
Based on this, IgG levels against As37 (from Ascaris spp.), NIE (from S. stercoralis) and MEA (from Schistosoma spp.) were able to perfectly separate the non-endemic population from the seropositive endemic population (Fig 9). As16 (from Ascaris spp.), NaAPR1, NaGST1, NaSAA2 (from hookworm) and Tm16 (from Trichuris spp.) also had quite good performance in distinguishing the non-endemic population from the seropositive endemic population with the only exceptions of a few outliers among the non-exposed individuals (Fig 9). On the contrary, IgG levels against AyCp2 (from hookworm), TmWAP (from Trichuris spp.) and Sm25 (from Schistosoma spp.), were elevated in the non-endemic population (Fig 9) suggesting low specificity.
Fig 9. Helminth antigen-specific IgG levels in non-endemic and endemic populations and seropositivity cutoffs by the Expectation-Maximization algorithm.
Antibody levels are presented as the log10-transformed median fluorescence intensity (MFI) of IgG against helminth antigens. In the endemic population, filled dots highlight individuals with a helminth infection with the corresponding parasite for each antigen detected by microscopy and/or qPCR. The dashed line represents the serology cutoff calculated with the Expectation-Maximization algorithm. Individuals above (orange) or below (grey) this cutoff were considered seropositive or seronegative, respectively. At the top of each plot, the absolute number and percentage of seropositive individuals with respect to the Non-Endemic (NE) (N = 50) or Endemic (E) (N = 715) populations are indicated. The boxplots represent the median (bold line), the mean (black diamond), the first and third quartiles (box) and the largest and smallest values within 1.5 times the interquartile range (whiskers). Data beyond the end of the whiskers are outliers.
In the case of P. falciparum antigens, IgG levels against α-gal, MSP1 block 2 and MSP2 perfectly distinguished the non-endemic population from the seropositive endemic population (Fig 10). IgG levels against AMA1, EBA175, EXP1, LSA1, MSP142, MSP5, RH1, RH5 and PTRAMP also distinguished the non-endemic population from the seropositive endemic population with the only exceptions of a few outliers among the non-exposed individuals (Fig 10). Finally, IgG levels against CelTOS, MSP3, P41 and, specially, SSP2, were elevated in the non-endemic population (Fig 10).
Fig 10. Plasmodium falciparum antigen-specific IgG levels in non-endemic and endemic populations and seropositivity cutoffs by the Expectation-Maximization algorithm.
Antibody levels are presented as the log10-transformed median fluorescence intensity (MFI) of IgG against P. falciparum antigens. In the endemic population, filled dots highlight individuals with a P. falciparum infection detected by qPCR. The dashed line represents the serology cutoff calculated with the Expectation-Maximization algorithm. Individuals above (orange) or below (grey) this cutoff were considered seropositive or seronegative, respectively. At the top of each plot, the absolute number and percentage of seropositive individuals with respect to the Non-Endemic (NE) (N = 50) or Endemic (E) (N = 715) populations are indicated. The boxplots represent the median (bold line), the mean (black diamond), the first and third quartiles (box) and the largest and smallest values within 1.5 times the interquartile range (whiskers). Data beyond the end of the whiskers are outliers.
Discussion
Antibody serology is a useful tool that can be exploited not only for understanding and detecting immunity to infections, but also for monitoring exposure and current infection. Here, we evaluated the ability of serology, measuring total IgE and specific IgG against a panel of STH, Schistosoma spp. and P. falciparum antigens, to detect current infection compared to microscopy, molecular diagnosis or the combination of both diagnoses, and to detect past exposure. Our study has proved the feasibility to use qSAT to measure antibody levels against a large panel of parasite antigens in serum eluted from DBS. The fact that Luminex allows for multiplexing several antigens with a very small amount of sample shows an advantage over conventional ELISAs, since it could be easily implemented for the detection of antibody responses to several pathogens simultaneously, and allows the integration of control programs for different pathogens. In addition, finger-pricking for the collection of DBS is a minimally invasive technique and is particularly practical for remote health and surveillance programs, since it offers simplified logistics and it is more cost effective than serum collection.
While IgG levels against most of the helminth antigens included in our panel were not good markers of current infection, many might be good enough markers of exposure. IgG to NIE (S. stercoralis), MEA and Sm25 (Schistosoma spp.), and MSP2 (P. falciparum) antigens showed the most promising results in detecting current infection. This is of particular interest for S. stercoralis due to the need for improved diagnosis. Microscopic examination has a very low sensitivity [44,45], as we have also verified by comparing the low number of S. stercoralis positive individuals detected by microscopy with those detected by qPCR. However, qPCR and other methods with better sensitivity than microscopy, such as the Baermann technique and Koga agar plate culture, could still leave out some infections given the frequency of low-burden infections [45]. Serological tests based on the detection of antibodies to whole S. stercoralis parasites or crude extracts have already shown excellent results [44,45]. Nonetheless, the need for a constant supply of parasites and variability of the source are limitations of those assays [46]. On the other hand, antibody serological methods based on recombinant proteins, such as NIE [47], are more reproducible. Recently, a study evaluated the performance of two ELISAs that detect IgG and IgG4 against NIE and S. stercoralis immunoreactive (SsIR) antigen and found specificities between 91–98% and sensitivities between 78–92% [48]. In our study, the cutoff with the maximum Youden’s index results in specificity and sensitivity of around 79% and 85%, respectively. One source of variations in accuracy is cross-reactivity. For example, the AUC for IgG against NIE increased and reached high accuracy after elimination of those samples from participants with other helminth and P. falciparum infections detected in our study. This informs of a possible cross-reactivity with other species and therefore accuracy might vary depending on the prevalence of other infections in the target area. This is particularly relevant for international travelers and people living in very low prevalence settings for co-infections. However, a study using NIE serology found no cross-reactivity between S. stercoralis and infections with other STH [49].
Interestingly, our results indicate that infection by Schistosoma spp. was associated with increased levels to NIE, AMA1 and MSP2, among others in the panel, and infection by S. stercoralis was associated with elevated IgG levels to all antigens. Such generalized pattern would suggest other mechanisms rather than cross-reactivity, like induction of polyreactive antibodies [50,51]. Another possibility is that increased antibody levels simply reflect an increased susceptibility and exposure to infections among Schistosoma spp. and S. stercoralis infected individuals. In any case, it should be considered that these infections might reduce the specificity of the assay, resulting in false positive results. These findings also underscore the importance of evaluating antibody serological tools in areas of co-endemicity. Conversely, the opposite pattern has been associated with T. trichiura infected individuals, in which IgG levels were generally lower than the non-infected individuals. This suggests a possible immunomodulation by T. trichiura as observed by others [52] which could reduce the sensitivity of the assay.
The WHO included the control of morbidity caused by S. stercoralis as one of its objectives for 2030 [1] and in September 2020 there was a WHO meeting to discuss diagnostic methods for the control of strongyloidiasis [11]. The control strategy is based on the distribution of ivermectin using established platforms to control other STH, and pilot interventions are currently being evaluated [1]. Such control strategies require monitoring of the transmission in order to guide future steps of the program. According to the meeting, serological assessment by NIE ELISA is the best available option, although it is not perfect and it should be accompanied by a Baermann or agar-plate method whenever possible [11]. NIE has been used in different platforms including ELISA, Luminex and luciferase immunoprecipitation system (LIPS) [48,49,53]. Also, it has been proposed as a valuable point-of-care diagnostic tool for its use in lateral flow cassettes [54,55]. While NIE serology shows promising results as a diagnostic tool, it is important to consider that total serological reversion is unlikely to occur and, therefore, differentiating between past exposure and current infection can be challenging. However, unlike for other parasitic infections, S. stercoralis-specific antibodies decrease markedly within the following months post-treatment [11,12] and, as we and others have demonstrated, it is possible to achieve a moderate to high accuracy based on antibody levels. This is particularly useful to evaluate the success of chemotherapy or MDA and verify transmission interruption [14,15].
Regarding Schistosoma spp., antibody serology is a valuable screening tool in non-endemic or low-transmission areas [19]. In addition, the WHO strategy for control of Schistosoma spp. infections is based on administration of preventive chemotherapy at large scale. Therefore, for the same reasons mentioned above for S. stercoralis, serology could be a valuable tool to inform decisions in the program. In our study, the cutoff with the maximum Youden’s index for IgG against MEA and Sm25 antigens showed sensitivities of 59–84% and 56–75%, respectively, and specificities of 54–69% and 63–85%, respectively. The wide range is affected by the diagnostic method and the species used as a reference. In fact, the genus-specific qPCR was a potential limitation since S. haematobium can also be detected in feces [56]. Therefore, the inability to distinguish species could have affected the accuracy of MEA and Sm25. In addition, better specificities and sensitivities are also possible depending on the cutoff method selected. Other studies with other antigens and platforms have found also a wide range of specificity and sensitivity with different assays [18,19] and have reported a limited utility of Schistosoma spp. serology in the detection of current infection in individuals from endemic areas or in the follow-up after treatment [46]. The reason for this is that antibody levels may remain elevated for a long period of time after elimination of the infection, contrary to what it is observed for S. stercoralis [19,57]. The Sm25 antigen has been evaluated previously and it was proposed as an excellent antigen for measuring responses to S. mansoni [58]. However, we observed a similar accuracy when the reference species was S. haematobium. Thus, it most likely detects both Schistosoma species due to cross-reactivity.
Specific IgG against many of the P. falciparum antigens from our panel were moderately good in detecting current infection, especially IgG against MSP2. In addition, for EXP1, AMA1 and MSP2, the accuracy particularly increased to high levels in children after stratification by age group, presumably because there is less interference from past exposures compared to adults, as observed also by others for other P. falciparum antigens [27]. IgG levels against these antigens were also very low in the non-endemic population. Given the long-lived nature of antibody responses, especially in endemic areas, it is unlikely that antibody responses find a niche among P. falciparum diagnostic methods, although others have identified antibody responses against different antigens from P. falciparum [59,60] and P. vivax [61] as potential markers of recent exposure. Our results suggest that IgG against the antigens in our panel could be useful markers in the context of control and elimination programs to monitor transmission using children as sentinels in medium- to high-transmission areas, where long-lasting antibody responses in adults might not represent the current transmission scenario. In addition, serology might be particularly relevant in areas of low transmission where large sample size are required to monitor prevalence and the use of other methods such as qPCR or microscopy would require high costs [27], time and would not be able to capture recent exposure. Additional longitudinal studies with a larger sample size in different age groups and areas of varying transmissions would be necessary to corroborate the utility of the markers proposed here as reliable indicators of infection. Interestingly, our results align with others that found IgG to MSP2 among the top 10 responses predictive of malaria incidence in study participants [62], a strong correlation of IgG to AMA1 with both clinical malaria and asymptomatic infection [60] and IgG to AMA1 and different allelic variants of MSP2 among the top performers of recent malaria exposure markers in a Kenyan children population [63]. However, the use of these antigens also comes with potential disadvantages. MSP2 is a highly polymorphic antigen [64,65] and therefore, the genotypes prevalent in the community might differ from that included in the assay [66]. As for EXP1, and specially AMA1, their high immunogenicity leads to high levels that reach saturation since early age at high transmission intensities, but they might be suitable for low transmission intensities [66]. Interestingly, the FlexMAP 3D platform from Luminex has a wider dynamic range compared to other platforms such as the Luminex 200 or ELISA. We hypothesize that this probably allowed for the detection of increases induced by current infections with respect to the basal levels even for highly immunogenic antigens.
The comparison of seropositivity cutoffs estimated by different methods highlights the importance of setting the cutoffs based on the antibody data from the endemic target population, as opposed to the classic approach of using data from a non-endemic population as reference. The reason behind is to take background responses into account, which might differ depending on the origin of the samples. For instance, we have observed here an elevated NC cutoff for some antigens, which is suggestive of the presence of antibodies in the non-endemic population that cross-react with some of the antigens in our panel. We have provided an approach to calculate the seropositivity cutoffs based on the distribution of antibody levels in an endemic population using the EM algorithm, also previously used by others [67]. Other cutoffs extracted from the ROC curves provided varying sensitivities and specificities, sometimes at the expense of a much reduced balance between these parameters, which can be used in different scenarios. For example, in the context of public health, in low prevalence settings or control programs, particularly towards the final elimination stage, high sensitivity with a prioritization of a high specificity is desirable since it reduces the number of false positive results and saves unnecessary interventions [68]. On the contrary, in the context of individual-focused diagnosis, sensitivity might be prioritized over specificity. In non-endemic areas where the number of imported cases is low, it may be preferable to treat a false positive patient than leaving out a potential infection that can be more threatening in people from non-endemic settings due to inexistent immunity.
In addition to IgG, IgG subclasses or other isotypes could be more useful for different species given the properties of each antibody type. For example, here we evaluated also total IgE responses, which are a well-known hallmark of the Th2 predominant responses typical of helminth infections [69]. IgE has a shorter half-life than IgG (~3 days versus ~21 days), which makes it a good candidate of recent exposure to helminths [70]. We have found that total IgE levels are a good marker of hookworm and Schistosoma spp. recent infections with moderate accuracy. Besides IgE, other studies have suggested Ascaris-specific IgG4 to perform better since it showed less cross-reactivity with other helminths than IgG1, IgG2 and IgG3 [71,72]. Moreover, for P. falciparum, the long-standing issue of finding a good marker of recent exposure could also benefit from combining the right antigen with the detection by IgG3 antibodies. IgG3 is one of the main IgG subclasses produced during Plasmodium spp. infection and it has a shorter half-life compared to the rest of IgG subclasses (~7 days versus ~21 days) [73].
Many of the antigens included in the analysis were not reliable markers of current infection since they were not able to classify correctly the population based in the reference diagnostic methods and reach an AUC > 0.7. On one hand, IgG levels may stay elevated long after acute infection, leading to high residual responses from past infections in the exposed non-infected population. On the other hand, due to antibody dynamics, there is a window of time between infection and detection of antibody titers that should also be taken into account, but we could not account for this since we did not have information on the specific time of infection for each participant. For example, in our study, all malaria cases included were probably asymptomatic given the non-hospital setting of the study and it could be that many of these infections were recent. In addition, the specificity of the responses might be against antigens from a specific stage of the life cycle of the parasite that has not been reached yet. Other possible reasons for lack of accuracy are: i) the lack of a proper gold standard diagnostic method for some parasites; ii) the low immunogenicity of some antigens; iii) and shared epitopes between antigens leading to cross-reactive antibodies in the non-infected population. In relation to the lack of a proper gold standard for comparison, serology might be able to capture infections that yield a low number of diagnostic forms for microscopy such as chronic Schistosoma spp. infections, which are characterized by low or absent egg production [74]. For this reason, conventional microscopy is not completely optimal for the diagnosis of Schistosoma spp. and using it as a reference may result in a false low sensitivity.
The design of the current study is subject to other limitations. The Telemann technique used in this study for the detection of S. stercoralis by microscopy is not among the recommended methods and therefore, positive cases might have passed underdiagnosed. Moreover, although qPCR has in general a better sensitivity than microscopy, it should be noted that it might also detect genetic material of dead parasites after resolving the infection. In addition, it would have been ideal to have longitudinal data to properly evaluate exposure and time since infection within the endemic population. This limitation hampered the calculation of sensitivity in the exposure analysis. Therefore, at this stage, we can only suggest that the antigens proposed as potential markers of exposure have good specificities. However, further investigations with longitudinal data from the endemic population and travelers with known exposure are needed to establish their sensitivity to detect early or cumulative past exposure. We also acknowledge the difficulty of field implementation of Luminex equipment in low- and middle-income settings, but a reference lab with the necessary equipment could be in charge of processing the samples. Furthermore, it might be that other antigens would have had a better performance. For P. falciparum, there is more availability and characterization of antigens in comparison to helminths and we selected antigens found to be immunogenic and associated with protection in our previous studies and that represented each phase of the complex life cycle of the parasite. In the case of helminths, S. stercoralis NIE was selected based on the already known utility for diagnosis of S. stercoralis, but another option would have been the SsIR antigen [75]. In the case of Schistosoma spp., Sm25 and MEA are major proteins on the tegument and eggs, respectively. Other possible recombinant antigens to consider are the Serine Protease Inhibitor (SERPIN) from S. haematobium and S. mansoni [76]. As for the rest of STH, the antigens selected are all vaccine candidate antigens and represent accessible antigens to the immune system. There are other recombinant antigens for helminths that could have been considered such as Ascaris suum haemoglobin (AsHb) [77] or the Ancylostoma Secreted Proteins (ASP) 1 and 2, which are the most abundant L3 hookworm larvae secreted antigens [78]. Finally, lack of information on symptomatology can be a limitation since antibody signatures might differ depending on the clinical manifestations. However, the participants had low-intensity P. falciparum and helminth infections, which shows the ability of antibody serology against specific antigens to detect an active infection even at low density.
In conclusion, we provide evidence for the utility of serology as a marker of current infection with some parasitic infections of public health importance in a co-endemic population from Southern Mozambique. We corroborate the reported good accuracy of IgG against the NIE (S. stercoralis) and show that IgG against MEA, Sm25 (Schistosoma spp.), EXP1, AMA1 and MSP2 (P. falciparum) might also be markers of current infection reliable enough to be employed as decision-making tools within control and elimination programs. Importantly, antibody serology by Luminex allows for multiplexing and, therefore, integration of control programs for different pathogens in co-endemic areas. Furthermore, we also show that IgG seropositivity against many of the antigens differentiated the seropositive endemic population from the non-endemic populations, suggesting a low background in the non-endemic population and a potential role as markers of exposure that merits further assessment.
Supporting information
M: microscopy; P: qPCR; MP: microscopy and/or qPCR. Asc: A. lumbricoides; Hoo: hookworm; Tri: T. trichiura; Str: S. stercoralis; Sch: Schistosoma spp.; Sh: S. haematobium; Sm: S. mansoni; Hel: Any helminth; Pf: P. falciparum.
(DOCX)
Ag: Antigen; AUC: Area Under the Curve; CI: Confidence Interval; M: Microscopy; P: qPCR; MP: Microscopy and qPCR combined. Accuracy is null if AUC < 0.5, low if 0.5 ≤ AUC > 0.7, moderate if 0.7 ≤ AUC > 0.9 and high if AUC ≥ 0.9. For antigen-specific IgG, the sample size of the controls included always the 50 Spanish donors.
(DOCX)
Ag: Antigen; AUC: Area Under the Curve; CI: Confidence Interval; M: Microscopy; P: qPCR; MP: Microscopy and/or qPCR. Accuracy is null if AUC < 0.5, low if 0.5 ≤ AUC > 0.7, moderate if 0.7 ≤ AUC > 0.9 and high if AUC ≥ 0.9.
(DOCX)
AUC: Area Under the Curve; M: Microscopy; P: qPCR; MP: Microscopy and/or qPCR. Accuracy is null if AUC < 0.5, low if 0.5 ≤ AUC > 0.7, moderate if 0.7 ≤ AUC > 0.9 and high if AUC ≥ 0.9. *MSP1 block 2.
(DOCX)
Ag: Antigen; EM: Expectation-Maximization; NC: Negative Controls; SP: Specificity; SE: Sensitivity, C: Cutoff; M: Microscopy, P: qPCR; MP: Microscopy and/or qPCR. *MSP1 block 2.
(DOCX)
The predicted values fitted by regression models were used to build the Receiver operating characteristic (ROC) curves and calculate the corresponding areas under the curve (AUCs). The models were built using the combination of log10-transformed median fluorescence intensity (MFI) as predictor variable and the Microscopic (M), qPCR (P) or the combination of both (MP) diagnoses were used as response variables. For Schistosoma spp. (A), the combination of the MFI from the two antigens in the panel was used. For P. falciparum the combination of the MFI from antigens that gave the best AUC with the lowest number of predictors is represented. We included only the top performer antigens to calculate the combinations, whether it was for the whole population (B) or stratified by age (C, children; D, adults). To build the models, serum samples from 715 endemic individuals and 50 Spanish donors were used. S spp.: Schistosoma spp.; Sh: Schistosoma haematobium; Sm: Schistosoma mansoni.
(DOCX)
Antibody levels are presented as the log10-transformed median fluorescence intensity (MFI) of IgG against helminth antigens. In the endemic population, filled dots highlight individuals with a helminth infection with the corresponding parasite for each antigen detected by microscopy and/or qPCR. The boxplots represent the median (bold line), the mean (black diamond), the first and third quartiles (box) and the largest and smallest values within 1.5 times the interquartile range (whiskers). Data beyond the end of the whiskers are outliers. Cutoff95SE: cutoff prioritizing a minimum sensitivity of 95%; Cutoff95SP: cutoff prioritizing a minimum specificity of 95%; CutoffYI: cutoff corresponding to the maximum Youden’s Index; CutoffEM: cutoff defined by the Expectation-Maximization algorithm; CutoffNC: cutoff calculated as mean + 3*standard deviations of the log10-transformed MFI levels from the non-endemic population. NE: Non-Endemic (N = 50), E: Endemic (N = 715). The rest of the antigens are in Fig 7.
(DOCX)
Antibody levels are presented as the log10-transformed median fluorescence intensity (MFI) of IgG against P. falciparum antigens. In the endemic population, filled dots highlight individuals with a P. falciparum infection detected by qPCR. The boxplots represent the median (bold line), the mean (black diamond), the first and third quartiles (box) and the largest and smallest values within 1.5 times the interquartile range (whiskers). Data beyond the end of the whiskers are outliers. Cutoff95SE: cutoff prioritizing a minimum sensitivity of 95%; Cutoff95SP: cutoff prioritizing a minimum specificity of 95%; CutoffYI: cutoff corresponding to the maximum Youden’s Index; CutoffEM: cutoff defined by the Expectation-Maximization algorithm; CutoffNC: cutoff calculated as mean + 3*standard deviations of the log10-transformed MFI levels from the non-endemic population. NE: Non-Endemic (N = 50), E: Endemic (N = 715). The rest of the antigens are in Fig 7.
(DOCX)
Only individuals with single infections or no infections at all detected by the combination of microscopy and qPCR are shown. Antibody levels are presented as the log10-transformed median fluorescence intensity (MFI) of IgG against helminth antigens. For each antigen, antibody levels for each species were compared to the levels of those with no infection and the corresponding species to the antigen was shown as a reference. Statistical comparison between groups was performed by Wilcoxon rank-sum test and the adjusted P values by the Holm approach are shown. Statistically significant P values are highlighted in bold. The sample size of each group is shown below each boxplot. The boxplots represent the median (bold line), the mean (black diamond), the first and third quartiles (box) and the largest and smallest values within 1.5 times the interquartile range (whiskers). Data beyond the end of the whiskers are outliers. Cutoff95SE: cutoff prioritizing a minimum sensitivity of 95%; Cutoff95SP: cutoff prioritizing a minimum specificity of 95%; CutoffYI: cutoff corresponding to the maximum Youden’s Index; CutoffEM: cutoff defined by the Expectation-Maximization algorithm; CutoffNC: cutoff calculated as mean + 3*standard deviations of the log10-transformed MFI levels from the non-endemic population. The rest of the antigens are in Fig 8.
(DOCX)
Only individuals with single infections or no infections at all detected by the combination of microscopy and qPCR are shown. Antibody levels are presented as the log10-transformed median fluorescence intensity (MFI) of IgG against P. falciparum antigens. For each antigen, antibody levels for each species were compared to the levels of those with no infection and the corresponding species to the antigen was shown as a reference. Statistical comparison between groups was performed by Wilcoxon rank-sum test and the adjusted P values by the Holm approach are shown. Statistically significant P values are highlighted in bold. The sample size of each group is shown below each boxplot. The boxplots represent the median (bold line), the mean (black diamond), the first and third quartiles (box) and the largest and smallest values within 1.5 times the interquartile range (whiskers). Data beyond the end of the whiskers are outliers. Cutoff95SE: cutoff prioritizing a minimum sensitivity of 95%; Cutoff95SP: cutoff prioritizing a minimum specificity of 95%; CutoffYI: cutoff corresponding to the maximum Youden’s Index; CutoffEM: cutoff defined by the Expectation-Maximization algorithm; CutoffNC: cutoff calculated as mean + 3*standard deviations of the log10-transformed MFI levels from the non-endemic population. The rest of the antigens are in Fig 8.
(DOCX)
Acknowledgments
We are grateful to the volunteers and their families and to all field workers and lab technicians that participated in this study. We also thank CISM Demography and Social Sciences department for their indispensable assistance during field work. Special thanks to the team members from ISGlobal, specifically Laura Puyol for the organization and coordination of shipment of samples, Pau Cisteró for the assistance in setting up the P. falciparum qPCR, Diana Barrios and Alfons Jiménez for the technical support in the lab, Miquel Vázquez-Santiago and Llorenç Quintó for the statistical advice, and Chenjerai Jairoce for the aid in assay optimization. For antigen procurement, we also thank Thomas Nutman (NIH/NIAID, USA), Sukwan Handali (CDC, USA) and Deepak Gaur (ICGEB and Jawaharlal Nehru University, India). On qPCR analysis, we particularly would like to thank Eric Brienen (LUMC, the Netherlands).
Data Availability
Data cannot be shared publicly because of participants consent restrains. However, data will be available on a reasonable request to the external data management unit in ISGlobal (ubioesdm@isglobal.es).
Funding Statement
This study was supported by the grant from “Instituto de Salud Carlos III” (ISCIII), co-financed by the European Regional Development Fund (ERDF) from the European Union, through the “Fondo de Investigación para la Salud” (FIS) awarded to CD (PI20/00866). BGP and JM received financial support for MARS study from Mundo Sano Foundation (www.mundosano.org). LI was supported by grant PID2019-110810RB-I00 by the Spanish Ministry of Science and Innovation. RS had the support of the Spanish Ministry of Science and Innovation (FPU2017/03390). LvL and MD were funded by the EDCTP2 program supported by the European Union (grant number RIA2017NCT-1845 STOP; www.stoptheworm.org). The Prof. Dr. PC Flu Foundation co-funded the helminth qPCR analysis. CISM is supported by the Government of Mozambique and the Spanish Agency for International Development (AECID). This research was part of the ISGlobal’s Program on the Molecular Mechanisms of Malaria, which is partially supported by the “Fundación Ramón Areces” and we acknowledge support from the Spanish Ministry of Science and Innovation through the ”Centro de Excelencia Severo Ochoa 2019–2023” Program (CEX2018-000806-S), and support from the “Generalitat de Catalunya” through the CERCA Program. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.
References
- 1.World Health Organization. Soil-transmitted helminth infections [Internet]. 2022. Available from: https://www.who.int/news-room/fact-sheets/detail/soil-transmitted-helminth-infections. [Google Scholar]
- 2.World Health Organization. Schistosomiasis [Internet]. 2022. Available from: https://www.who.int/news-room/fact-sheets/detail/schistosomiasis. [Google Scholar]
- 3.World Health Organization. World malaria report 2021. Geneva; 2021.
- 4.Salgame P, Yap GS, Gause WC. Effect of helminth-induced immunity on infections with microbial pathogens. Nat Immunol. 2013. Nov;14(11):1118–26. doi: 10.1038/ni.2736 [DOI] [PMC free article] [PubMed] [Google Scholar]
- 5.Doehring E, Feldmeier H, Daffalla AA. Day-to-day variation and circadian rhythm of egg excretion in urinary schistosomiasis in the Sudan. Ann Trop Med Parasitol. 1983. Dec;77(6):587–94. doi: 10.1080/00034983.1983.11811757 [DOI] [PubMed] [Google Scholar]
- 6.Hall A. Quantitative variability of nematode egg counts in faeces: a study among rural Kenyans. Trans R Soc Trop Med Hyg. 1981;75(5):682–7. doi: 10.1016/0035-9203(81)90148-6 [DOI] [PubMed] [Google Scholar]
- 7.Anderson RM, Schad GA. Hookworm burdens and faecal egg counts: an analysis of the biological basis of variation. Trans R Soc Trop Med Hyg. 1985;79(6):812–25. doi: 10.1016/0035-9203(85)90128-2 [DOI] [PubMed] [Google Scholar]
- 8.Dreyer G, Fernandes-Silva E, Alves S, Rocha A, Albuquerque R, Addiss D. Patterns of detection of Strongyloides stercoralis in stool specimens: implications for diagnosis and clinical trials. J Clin Microbiol. 1996. Oct;34(10):2569–71. doi: 10.1128/jcm.34.10.2569-2571.1996 [DOI] [PMC free article] [PubMed] [Google Scholar]
- 9.Werkman M, Wright JE, Truscott JE, Oswald WE, Halliday KE, Papaiakovou M, et al. The impact of community-wide, mass drug administration on aggregation of soil-transmitted helminth infection in human host populations. Parasites & Vectors. 2020;13(1):290. doi: 10.1186/s13071-020-04149-4 [DOI] [PMC free article] [PubMed] [Google Scholar]
- 10.Gitta B, Kilian N. Diagnosis of Malaria Parasites Plasmodium spp. in Endemic Areas: Current Strategies for an Ancient Disease. BioEssays. 2020. Jan 1;42(1):1900138. doi: 10.1002/bies.201900138 [DOI] [PubMed] [Google Scholar]
- 11.World Health Organization. Diagnostic methods for the control of strongyloidiasis, Virtual meeting, 29 September 2020. Geneva; 2020.
- 12.Buonfrate D, Sequi M, Mejia R, Cimino RO, Krolewiecki AJ, Albonico M, et al. Accuracy of Five Serologic Tests for the Follow up of Strongyloides stercoralis Infection. PLOS Neglected Tropical Diseases. 2015. Feb 10;9(2):e0003491. doi: 10.1371/journal.pntd.0003491 [DOI] [PMC free article] [PubMed] [Google Scholar]
- 13.Balachandra D, Ahmad H, Arifin N, Noordin R. Direct detection of Strongyloides infection via molecular and antigen detection methods. European journal of clinical microbiology & infectious diseases: official publication of the European Society of Clinical Microbiology. 2021. Jan;40(1):27–37. doi: 10.1007/s10096-020-03949-x [DOI] [PubMed] [Google Scholar]
- 14.Marks M, Gwyn S, Toloka H, Kositz C, Asugeni J, Asugeni R, et al. Impact of Community Treatment With Ivermectin for the Control of Scabies on the Prevalence of Antibodies to Strongyloides stercoralis in Children. Clinical Infectious Diseases. 2020. Dec 15;71(12):3226–8. doi: 10.1093/cid/ciaa584 [DOI] [PMC free article] [PubMed] [Google Scholar]
- 15.Mounsey K, Kearns T, Rampton M, Llewellyn S, King M, Holt D, et al. Use of dried blood spots to define antibody response to the Strongyloides stercoralis recombinant antigen NIE. Acta Trop. 2014. Oct;138:78–82. doi: 10.1016/j.actatropica.2014.07.007 [DOI] [PMC free article] [PubMed] [Google Scholar]
- 16.Vlaminck J, Supali T, Geldhof P, Hokke CH, Fischer PU, Weil GJ. Community Rates of IgG4 Antibodies to Ascaris Haemoglobin Reflect Changes in Community Egg Loads Following Mass Drug Administration. PLoS Negl Trop Dis. 2016. Mar;10(3):e0004532. doi: 10.1371/journal.pntd.0004532 [DOI] [PMC free article] [PubMed] [Google Scholar]
- 17.Logan J, Pearson MS, Manda SS, Choi YJ, Field M, Eichenberger RM, et al. Comprehensive analysis of the secreted proteome of adult Necator americanus hookworms. PLOS Neglected Tropical Diseases. 2020. May 26;14(5):e0008237. doi: 10.1371/journal.pntd.0008237 [DOI] [PMC free article] [PubMed] [Google Scholar]
- 18.Kinkel HF, Dittrich S, Bäumer B, Weitzel T. Evaluation of eight serological tests for diagnosis of imported schistosomiasis. Clin Vaccine Immunol. 2012/03/21. 2012. Jun;19(6):948–53. doi: 10.1128/CVI.05680-11 [DOI] [PMC free article] [PubMed] [Google Scholar]
- 19.Hinz R, Schwarz NG, Hahn A, Frickmann H. Serological approaches for the diagnosis of schistosomiasis–A review. Molecular and Cellular Probes. 2017;31:2–21. doi: 10.1016/j.mcp.2016.12.003 [DOI] [PubMed] [Google Scholar]
- 20.Drakeley C, Cook J. Chapter 5 Potential Contribution of Sero-Epidemiological Analysis for Monitoring Malaria Control and Elimination: Historical and Current Perspectives. In Academic Press; 2009. p. 299–352. Available from: https://linkinghub.elsevier.com/retrieve/pii/S0065308X09690059. [DOI] [PubMed] [Google Scholar]
- 21.Drakeley CJ, Corran PH, Coleman PG, Tongren JE, McDonald SLR, Carneiro I, et al. Estimating medium- and long-term trends in malaria transmission by using serological markers of malaria exposure. Proc Natl Acad Sci U S A. 2005. Apr 5;102(14):5108 LP–5113. doi: 10.1073/pnas.0408725102 [DOI] [PMC free article] [PubMed] [Google Scholar]
- 22.Won KY, Sambou S, Barry A, Robinson K, Jaye M, Sanneh B, et al. Use of Antibody Tools to Provide Serologic Evidence of Elimination of Lymphatic Filariasis in The Gambia. The American Journal of Tropical Medicine and Hygiene. 2018;98(1):15–20. doi: 10.4269/ajtmh.17-0371 [DOI] [PMC free article] [PubMed] [Google Scholar]
- 23.Guevara Á, Salazar E, Vicuña Y, Hassan HK, Muro A, Guderian R, et al. Use of Ov16-Based Serology for Post-Elimination Surveillance of Onchocerciasis in Ecuador. The American Journal of Tropical Medicine and Hygiene. 2020;103(4):1569–71. doi: 10.4269/ajtmh.20-0082 [DOI] [PMC free article] [PubMed] [Google Scholar]
- 24.Pinsent A, Solomon AW, Bailey RL, Bid R, Cama A, Dean D, et al. The utility of serology for elimination surveillance of trachoma. Nature Communications. 2018;9(1):5444. doi: 10.1038/s41467-018-07852-0 [DOI] [PMC free article] [PubMed] [Google Scholar]
- 25.Rabello AL, Garcia MM, Pinto da Silva RA, Rocha RS, Katz N. Humoral immune responses in patients with acute Schistosoma mansoni infection who were followed up for two years after treatment. Clinical infectious diseases: an official publication of the Infectious Diseases Society of America. 1997. Mar;24(3):304–8. doi: 10.1093/clinids/24.3.304 [DOI] [PubMed] [Google Scholar]
- 26.Doenhoff MJ, Chiodini PL, Hamilton J V. Specific and sensitive diagnosis of schistosome infection: can it be done with antibodies? Trends Parasitol. 2004. Jan;20(1):35–9. doi: 10.1016/j.pt.2003.10.019 [DOI] [PubMed] [Google Scholar]
- 27.Markwalter CF, Nyunt MH, Han ZY, Henao R, Jain A, Taghavian O, et al. Antibody signatures of asymptomatic Plasmodium falciparum malaria infections measured from dried blood spots. Malaria Journal. 2021;20(1):378. doi: 10.1186/s12936-021-03915-8 [DOI] [PMC free article] [PubMed] [Google Scholar]
- 28.Santano R, Rubio R, Grau-Pujol B, Escola V, Muchisse O, Cuamba I, et al. Plasmodium falciparum and Helminth Coinfections Increase IgE and Parasite-Specific IgG Responses. Microbiol Spectr. 2021. Dec 8;e0110921. doi: 10.1128/Spectrum.01109-21 [DOI] [PMC free article] [PubMed] [Google Scholar]
- 29.Saúte F, Aponte J, Almeda J, Ascaso C, Vaz N, Dgedge M, et al. Malaria in southern Mozambique: incidence of clinical malaria in children living in a rural community in Manhiça district. Trans R Soc Trop Med Hyg. 2003;97(6):655–60. doi: 10.1016/s0035-9203(03)80097-4 [DOI] [PubMed] [Google Scholar]
- 30.Grau-Pujol B, Martí-Soler H, Escola V, Demontis M, Jamine JC, Gandasegui J, et al. Towards soil-transmitted helminths transmission interruption: The impact of diagnostic tools on infection prediction in a low intensity setting in Southern Mozambique. Beechler BR, editor. PLOS Neglected Tropical Diseases. 2021. Oct 25;15(10):e0009803. doi: 10.1371/journal.pntd.0009803 [DOI] [PMC free article] [PubMed] [Google Scholar]
- 31.Expanded Special Project for Elimination of Neglected Tropical Diseases (ESPEN). Mozambique [Internet]. [cited 2022 Mar 25]. Available from: https://espen.afro.who.int/countries/mozambique.
- 32.Grau-Pujol B, Cuamba I, Jairoce C, Cossa A, da Silva J, Sacoor C, et al. Molecular Detection of Soil-Transmitted Helminths and Enteric Protozoa Infection in Children and Its Association with Household Water and Sanitation in Manhiça District, Southern Mozambique. Pathogens. 2021. Jul 3;10(7). doi: 10.3390/pathogens10070838 [DOI] [PMC free article] [PubMed] [Google Scholar]
- 33.World Health Organization. World Malaria Report. Geneva; 2017.
- 34.Galatas B, Guinovart C, Bassat Q, Aponte JJ, Nhamússua L, Macete E, et al. A prospective cohort study to assess the micro-epidemiology of Plasmodium falciparum clinical malaria in Ilha Josina Machel (Manhiça, Mozambique). Malar J. 2016;15(1):444. doi: 10.1186/s12936-016-1496-y [DOI] [PMC free article] [PubMed] [Google Scholar]
- 35.World Health Organization. Basic laboratory methods in medical parasitology. 1991. [Google Scholar]
- 36.Telemann W. Eine Methode zur Erleichterung der Auffindung von Parasiteneiern in den Faeces. Deutsche Medizinische Wochenschrift. 1908;34(35):1510–1. [Google Scholar]
- 37.Robin X, Turck N, Hainard A, Tiberti N, Lisacek F, Sanchez JC, et al. pROC: an open-source package for R and S+ to analyze and compare ROC curves. BMC Bioinformatics. 2011. Mar 17;12:77. doi: 10.1186/1471-2105-12-77 [DOI] [PMC free article] [PubMed] [Google Scholar]
- 38.Scrucca L, Fop M, Murphy TB, Raftery AE. mclust 5: Clustering, Classification and Density Estimation Using Gaussian Finite Mixture Models. R J. 2016. Aug;8(1):289–317. [PMC free article] [PubMed] [Google Scholar]
- 39.Wickham H, Averick M, Bryan J, Chang W, McGowan L, François R, et al. Welcome to the Tidyverse. Journal of Open Source Software. 2019. Nov 21;4(43):1686. [Google Scholar]
- 40.Kassambara A. “ggplot2” Based Publication Ready Plots [R package ggpubr version 0.4.0]. 2020. Jun 27; [Google Scholar]
- 41.Clarke E, Sherrill-Mix SA. ggbeeswarm: Categorical scatter (violin point) plots [Internet]. R package version 0.6.0. 2017. [cited 2021 Apr 20]. Available from: https://rdrr.io/cran/ggbeeswarm/. [Google Scholar]
- 42.Conway JR, Lex A, Gehlenborg N. UpSetR: an R package for the visualization of intersecting sets and their properties. Bioinformatics. 2017. Sep 15;33(18):2938–40. doi: 10.1093/bioinformatics/btx364 [DOI] [PMC free article] [PubMed] [Google Scholar]
- 43.Swets JA. Measuring the accuracy of diagnostic systems. Science. 1988. Jun;240(4857):1285–93. doi: 10.1126/science.3287615 [DOI] [PubMed] [Google Scholar]
- 44.Requena-Méndez A, Chiodini P, Bisoffi Z, Buonfrate D, Gotuzzo E, Muñoz J. The laboratory diagnosis and follow up of strongyloidiasis: a systematic review. PLoS Negl Trop Dis. 2013/01/17. 2013;7(1):e2002–e2002. doi: 10.1371/journal.pntd.0002002 [DOI] [PMC free article] [PubMed] [Google Scholar]
- 45.Buonfrate D, Formenti F, Perandin F, Bisoffi Z. Novel approaches to the diagnosis of Strongyloides stercoralis infection. Clinical Microbiology and Infection. 2015. Jun 1;21(6):543–52. doi: 10.1016/j.cmi.2015.04.001 [DOI] [PubMed] [Google Scholar]
- 46.Tamarozzi F, Ursini T, Hoekstra PT, Silva R, Costa C, Gobbi F, et al. Evaluation of microscopy, serology, circulating anodic antigen (CAA), and eosinophil counts for the follow-up of migrants with chronic schistosomiasis: a prospective cohort study. Parasit Vectors. 2021. Mar 9;14(1):149. doi: 10.1186/s13071-021-04655-z [DOI] [PMC free article] [PubMed] [Google Scholar]
- 47.Ravi V, Ramachandran S, Thompson RW, Andersen JF, Neva FA. Characterization of a recombinant immunodiagnostic antigen (NIE) from Strongyloides stercoralis L3-stage larvae. Mol Biochem Parasitol. 2002;125(1–2):73–81. doi: 10.1016/s0166-6851(02)00214-1 [DOI] [PubMed] [Google Scholar]
- 48.Tamarozzi F, Longoni SS, Mazzi C, Pettene S, Montresor A, Mahanty S, et al. Diagnostic accuracy of a novel enzyme-linked immunoassay for the detection of IgG and IgG4 against Strongyloides stercoralis based on the recombinant antigens NIE/SsIR. Parasites & Vectors. 2021;14(1):412. doi: 10.1186/s13071-021-04916-x [DOI] [PMC free article] [PubMed] [Google Scholar]
- 49.Krolewiecki AJ, Ramanathan R, Fink V, McAuliffe I, Cajal SP, Won K, et al. Improved diagnosis of Strongyloides stercoralis using recombinant antigen-based serologies in a community-wide study in northern Argentina. Clin Vaccine Immunol. 2010. Oct;17(10):1624–30. doi: 10.1128/CVI.00259-10 [DOI] [PMC free article] [PubMed] [Google Scholar]
- 50.Dimitrov JD, Planchais C, Roumenina LT, Vassilev TL, Kaveri S V, Lacroix-Desmazes S. Antibody Polyreactivity in Health and Disease: Statu Variabilis. The Journal of Immunology. 2013. Aug 1;191(3):993 LP–999. doi: 10.4049/jimmunol.1300880 [DOI] [PubMed] [Google Scholar]
- 51.Patel P, Kearney JF. Immunological Outcomes of Antibody Binding to Glycans Shared between Microorganisms and Mammals. The Journal of Immunology. 2016. Dec 1;197(11):4201 LP–4209. doi: 10.4049/jimmunol.1600872 [DOI] [PMC free article] [PubMed] [Google Scholar]
- 52.Esen M, Mordmüller B, de Salazar PM, Adegnika AA, Agnandji ST, Schaumburg F, et al. Reduced antibody responses against Plasmodium falciparum vaccine candidate antigens in the presence of Trichuris trichiura. Vaccine. 2012. Dec;30(52):7621–4. doi: 10.1016/j.vaccine.2012.10.026 [DOI] [PubMed] [Google Scholar]
- 53.Rascoe LN, Price C, Shin SH, McAuliffe I, Priest JW, Handali S. Development of Ss-NIE-1 Recombinant Antigen Based Assays for Immunodiagnosis of Strongyloidiasis. PLoS Neglected Tropical Diseases. 2015;9(4):1–10. doi: 10.1371/journal.pntd.0003694 [DOI] [PMC free article] [PubMed] [Google Scholar]
- 54.Yunus MH, Arifin N, Balachandra D, Anuar NS, Noordin R. Lateral Flow Dipstick Test for Serodiagnosis of Strongyloidiasis. Am J Trop Med Hyg. 2019. Aug;101(2):432–5. doi: 10.4269/ajtmh.19-0053 [DOI] [PMC free article] [PubMed] [Google Scholar]
- 55.Noordin R, Osman E, Kalantari N, Anuar NS, Gorgani-Firouzjaee T, Sithithaworn P, et al. A point-of-care cassette test for detection of Strongyloides stercoralis. Acta Tropica. 2022;226:106251. doi: 10.1016/j.actatropica.2021.106251 [DOI] [PubMed] [Google Scholar]
- 56.Cunin P, Tchuem Tchuenté LA, Poste B, Djibrilla K, Martin PM V. Interactions between Schistosoma haematobium and Schistosoma mansoni in humans in north Cameroon. Trop Med Int Health. 2003. Dec;8(12):1110–7. doi: 10.1046/j.1360-2276.2003.01139.x [DOI] [PubMed] [Google Scholar]
- 57.Yong MK, Beckett CL, Leder K, Biggs BA, Torresi J, O’Brien DP. Long-Term Follow-Up of Schistosomiasis Serology Post-Treatment in Australian Travelers and Immigrants. Journal of Travel Medicine. 2010. Mar 1;17(2):89–93. doi: 10.1111/j.1708-8305.2009.00379.x [DOI] [PubMed] [Google Scholar]
- 58.Njenga SM, Kanyi HM, Arnold BF, Matendechero SH, Onsongo JK, Won KY, et al. Integrated Cross-Sectional Multiplex Serosurveillance of IgG Antibody Responses to Parasitic Diseases and Vaccines in Coastal Kenya. Am J Trop Med Hyg. 2020. Jan;102(1):164–76. doi: 10.4269/ajtmh.19-0365 [DOI] [PMC free article] [PubMed] [Google Scholar]
- 59.van den Hoogen LL, Walk J, Oulton T, Reuling IJ, Reiling L, Beeson JG, et al. Antibody Responses to Antigenic Targets of Recent Exposure Are Associated With Low-Density Parasitemia in Controlled Human Plasmodium falciparum Infections. Vol. 9, Frontiers in Microbiology. 2019. p. 3300. doi: 10.3389/fmicb.2018.03300 [DOI] [PMC free article] [PubMed] [Google Scholar]
- 60.Wu L, Mwesigwa J, Affara M, Bah M, Correa S, Hall T, et al. Antibody responses to a suite of novel serological markers for malaria surveillance demonstrate strong correlation with clinical and parasitological infection across seasons and transmission settings in The Gambia. BMC Medicine. 2020;18(1):304. doi: 10.1186/s12916-020-01724-5 [DOI] [PMC free article] [PubMed] [Google Scholar]
- 61.Longley RJ, White MT, Takashima E, Brewster J, Morita M, Harbers M, et al. Development and validation of serological markers for detecting recent Plasmodium vivax infection. Nature Medicine. 2020;26(5):741–9. doi: 10.1038/s41591-020-0841-4 [DOI] [PubMed] [Google Scholar]
- 62.Helb DA, Tetteh KKA, Felgner PL, Skinner J, Hubbard A, Arinaitwe E, et al. Novel serologic biomarkers provide accurate estimates of recent Plasmodium falciparum exposure for individuals and communities. Proceedings of the National Academy of Sciences. 2015. Aug 11;112(32):E4438 LP–E4447. doi: 10.1073/pnas.1501705112 [DOI] [PMC free article] [PubMed] [Google Scholar]
- 63.Yman V, Tuju J, White MT, Kamuyu G, Mwai K, Kibinge N, et al. Distinct kinetics of antibodies to 111 Plasmodium falciparum proteins identifies markers of recent malaria exposure. Nature Communications. 2022. Dec 17;13(1):331. doi: 10.1038/s41467-021-27863-8 [DOI] [PMC free article] [PubMed] [Google Scholar]
- 64.Franks S, Baton L, Tetteh K, Tongren E, Dewin D, Akanmori BD, et al. Genetic diversity and antigenic polymorphism in Plasmodium falciparum: extensive serological cross-reactivity between allelic variants of merozoite surface protein 2. Infect Immun. 2003. Jun;71(6):3485–95. doi: 10.1128/IAI.71.6.3485-3495.2003 [DOI] [PMC free article] [PubMed] [Google Scholar]
- 65.Hoffmann EH, da Silveira LA, Tonhosolo R, Pereira FJ, Ribeiro WL, Tonon AP, et al. Geographical patterns of allelic diversity in the Plasmodium falciparum malaria-vaccine candidate, merozoite surface protein-2. Ann Trop Med Parasitol. 2001. Mar;95(2):117–32. doi: 10.1080/00034980120045833 [DOI] [PubMed] [Google Scholar]
- 66.Corran P, Coleman P, Riley E, Drakeley C. Serology: a robust indicator of malaria transmission intensity? Trends Parasitol. 2007. Dec;23(12):575–82. doi: 10.1016/j.pt.2007.08.023 [DOI] [PubMed] [Google Scholar]
- 67.Migchelsen SJ, Martin DL, Southisombath K, Turyaguma P, Heggen A, Rubangakene PP, et al. Defining Seropositivity Thresholds for Use in Trachoma Elimination Studies. PLoS Negl Trop Dis. 2017. Jan 18;11(1):e0005230–e0005230. doi: 10.1371/journal.pntd.0005230 [DOI] [PMC free article] [PubMed] [Google Scholar]
- 68.Gass K. Time for a diagnostic sea-change: Rethinking neglected tropical disease diagnostics to achieve elimination. PLoS Negl Trop Dis. 2020. Dec 31;14(12):e0008933–e0008933. doi: 10.1371/journal.pntd.0008933 [DOI] [PMC free article] [PubMed] [Google Scholar]
- 69.Maizels RM, Balic A, Gomez-Escobar N, Nair M, Taylor MD, Allen JE. Helminth parasites–masters of regulation. Immunological Reviews. 2004. Oct 1;201(1):89–116. [DOI] [PubMed] [Google Scholar]
- 70.Lawrence MG, Woodfolk JA, Schuyler AJ, Stillman LC, Chapman MD, Platts-Mills TAE. Half-life of IgE in serum and skin: Consequences for anti-IgE therapy in patients with allergic disease. J Allergy Clin Immunol. 2016/07/14. 2017. Feb;139(2):422–428.e4. doi: 10.1016/j.jaci.2016.04.056 [DOI] [PMC free article] [PubMed] [Google Scholar]
- 71.Chatterjee BP, Santra A, Karmakar PR, Mazumder DN. Evaluation of IgG4 response in ascariasis by ELISA for serodiagnosis. Trop Med Int Health. 1996. Oct;1(5):633–9. doi: 10.1111/j.1365-3156.1996.tb00088.x [DOI] [PubMed] [Google Scholar]
- 72.Santra A, Bhattacharya T, Chowdhury A, Ghosh A, Ghosh N, Chatterjee BP, et al. Serodiagnosis of ascariasis with specific IgG4 antibody and its use in an epidemiological study. Trans R Soc Trop Med Hyg. 2001;95(3):289–92. doi: 10.1016/s0035-9203(01)90236-6 [DOI] [PubMed] [Google Scholar]
- 73.Vidarsson G, Dekkers G, Rispens T. IgG subclasses and allotypes: From structure to effector functions. Frontiers in Immunology. 2014;5(OCT):1–17. doi: 10.3389/fimmu.2014.00520 [DOI] [PMC free article] [PubMed] [Google Scholar]
- 74.McManus DP, Dunne DW, Sacko M, Utzinger J, Vennervald BJ, Zhou XN. Schistosomiasis. Nature Reviews Disease Primers. 2018;4(1):13. doi: 10.1038/s41572-018-0013-8 [DOI] [PubMed] [Google Scholar]
- 75.Ramanathan R, Burbelo PD, Groot S, Iadarola MJ, Neva FA, Nutman TB. A Luciferase Immunoprecipitation Systems Assay Enhances the Sensitivity and Specificity of Diagnosis of Strongyloides stercoralis Infection. The Journal of Infectious Diseases. 2008. Aug;198(3):444–51. doi: 10.1086/589718 [DOI] [PMC free article] [PubMed] [Google Scholar]
- 76.Tanigawa C, Fujii Y, Miura M, Nzou SM, Mwangi AW, Nagi S, et al. Species-Specific Serological Detection for Schistosomiasis by Serine Protease Inhibitor (SERPIN) in Multiplex Assay. PLOS Neglected Tropical Diseases. 2015. Aug 20;9(8):e0004021. doi: 10.1371/journal.pntd.0004021 [DOI] [PMC free article] [PubMed] [Google Scholar]
- 77.Dana D, Vlaminck J, Ayana M, Tadege B, Mekonnen Z, Geldhof P, et al. Evaluation of copromicroscopy and serology to measure the exposure to Ascaris infections across age groups and to assess the impact of 3 years of biannual mass drug administration in Jimma Town, Ethiopia. PLOS Neglected Tropical Diseases. 2020. Apr 13;14(4):e0008037. doi: 10.1371/journal.pntd.0008037 [DOI] [PMC free article] [PubMed] [Google Scholar]
- 78.Bethony J, Loukas A, Smout M, Brooker S, Mendez S, Plieskatt J, et al. Antibodies against a secreted protein from hookworm larvae reduce the intensity of hookworm infection in humans and vaccinated laboratory animals. The FASEB Journal. 2005. Oct 21;19(12):1743–5. doi: 10.1096/fj.05-3936fje [DOI] [PubMed] [Google Scholar]
Associated Data
This section collects any data citations, data availability statements, or supplementary materials included in this article.
Supplementary Materials
M: microscopy; P: qPCR; MP: microscopy and/or qPCR. Asc: A. lumbricoides; Hoo: hookworm; Tri: T. trichiura; Str: S. stercoralis; Sch: Schistosoma spp.; Sh: S. haematobium; Sm: S. mansoni; Hel: Any helminth; Pf: P. falciparum.
(DOCX)
Ag: Antigen; AUC: Area Under the Curve; CI: Confidence Interval; M: Microscopy; P: qPCR; MP: Microscopy and qPCR combined. Accuracy is null if AUC < 0.5, low if 0.5 ≤ AUC > 0.7, moderate if 0.7 ≤ AUC > 0.9 and high if AUC ≥ 0.9. For antigen-specific IgG, the sample size of the controls included always the 50 Spanish donors.
(DOCX)
Ag: Antigen; AUC: Area Under the Curve; CI: Confidence Interval; M: Microscopy; P: qPCR; MP: Microscopy and/or qPCR. Accuracy is null if AUC < 0.5, low if 0.5 ≤ AUC > 0.7, moderate if 0.7 ≤ AUC > 0.9 and high if AUC ≥ 0.9.
(DOCX)
AUC: Area Under the Curve; M: Microscopy; P: qPCR; MP: Microscopy and/or qPCR. Accuracy is null if AUC < 0.5, low if 0.5 ≤ AUC > 0.7, moderate if 0.7 ≤ AUC > 0.9 and high if AUC ≥ 0.9. *MSP1 block 2.
(DOCX)
Ag: Antigen; EM: Expectation-Maximization; NC: Negative Controls; SP: Specificity; SE: Sensitivity, C: Cutoff; M: Microscopy, P: qPCR; MP: Microscopy and/or qPCR. *MSP1 block 2.
(DOCX)
The predicted values fitted by regression models were used to build the Receiver operating characteristic (ROC) curves and calculate the corresponding areas under the curve (AUCs). The models were built using the combination of log10-transformed median fluorescence intensity (MFI) as predictor variable and the Microscopic (M), qPCR (P) or the combination of both (MP) diagnoses were used as response variables. For Schistosoma spp. (A), the combination of the MFI from the two antigens in the panel was used. For P. falciparum the combination of the MFI from antigens that gave the best AUC with the lowest number of predictors is represented. We included only the top performer antigens to calculate the combinations, whether it was for the whole population (B) or stratified by age (C, children; D, adults). To build the models, serum samples from 715 endemic individuals and 50 Spanish donors were used. S spp.: Schistosoma spp.; Sh: Schistosoma haematobium; Sm: Schistosoma mansoni.
(DOCX)
Antibody levels are presented as the log10-transformed median fluorescence intensity (MFI) of IgG against helminth antigens. In the endemic population, filled dots highlight individuals with a helminth infection with the corresponding parasite for each antigen detected by microscopy and/or qPCR. The boxplots represent the median (bold line), the mean (black diamond), the first and third quartiles (box) and the largest and smallest values within 1.5 times the interquartile range (whiskers). Data beyond the end of the whiskers are outliers. Cutoff95SE: cutoff prioritizing a minimum sensitivity of 95%; Cutoff95SP: cutoff prioritizing a minimum specificity of 95%; CutoffYI: cutoff corresponding to the maximum Youden’s Index; CutoffEM: cutoff defined by the Expectation-Maximization algorithm; CutoffNC: cutoff calculated as mean + 3*standard deviations of the log10-transformed MFI levels from the non-endemic population. NE: Non-Endemic (N = 50), E: Endemic (N = 715). The rest of the antigens are in Fig 7.
(DOCX)
Antibody levels are presented as the log10-transformed median fluorescence intensity (MFI) of IgG against P. falciparum antigens. In the endemic population, filled dots highlight individuals with a P. falciparum infection detected by qPCR. The boxplots represent the median (bold line), the mean (black diamond), the first and third quartiles (box) and the largest and smallest values within 1.5 times the interquartile range (whiskers). Data beyond the end of the whiskers are outliers. Cutoff95SE: cutoff prioritizing a minimum sensitivity of 95%; Cutoff95SP: cutoff prioritizing a minimum specificity of 95%; CutoffYI: cutoff corresponding to the maximum Youden’s Index; CutoffEM: cutoff defined by the Expectation-Maximization algorithm; CutoffNC: cutoff calculated as mean + 3*standard deviations of the log10-transformed MFI levels from the non-endemic population. NE: Non-Endemic (N = 50), E: Endemic (N = 715). The rest of the antigens are in Fig 7.
(DOCX)
Only individuals with single infections or no infections at all detected by the combination of microscopy and qPCR are shown. Antibody levels are presented as the log10-transformed median fluorescence intensity (MFI) of IgG against helminth antigens. For each antigen, antibody levels for each species were compared to the levels of those with no infection and the corresponding species to the antigen was shown as a reference. Statistical comparison between groups was performed by Wilcoxon rank-sum test and the adjusted P values by the Holm approach are shown. Statistically significant P values are highlighted in bold. The sample size of each group is shown below each boxplot. The boxplots represent the median (bold line), the mean (black diamond), the first and third quartiles (box) and the largest and smallest values within 1.5 times the interquartile range (whiskers). Data beyond the end of the whiskers are outliers. Cutoff95SE: cutoff prioritizing a minimum sensitivity of 95%; Cutoff95SP: cutoff prioritizing a minimum specificity of 95%; CutoffYI: cutoff corresponding to the maximum Youden’s Index; CutoffEM: cutoff defined by the Expectation-Maximization algorithm; CutoffNC: cutoff calculated as mean + 3*standard deviations of the log10-transformed MFI levels from the non-endemic population. The rest of the antigens are in Fig 8.
(DOCX)
Only individuals with single infections or no infections at all detected by the combination of microscopy and qPCR are shown. Antibody levels are presented as the log10-transformed median fluorescence intensity (MFI) of IgG against P. falciparum antigens. For each antigen, antibody levels for each species were compared to the levels of those with no infection and the corresponding species to the antigen was shown as a reference. Statistical comparison between groups was performed by Wilcoxon rank-sum test and the adjusted P values by the Holm approach are shown. Statistically significant P values are highlighted in bold. The sample size of each group is shown below each boxplot. The boxplots represent the median (bold line), the mean (black diamond), the first and third quartiles (box) and the largest and smallest values within 1.5 times the interquartile range (whiskers). Data beyond the end of the whiskers are outliers. Cutoff95SE: cutoff prioritizing a minimum sensitivity of 95%; Cutoff95SP: cutoff prioritizing a minimum specificity of 95%; CutoffYI: cutoff corresponding to the maximum Youden’s Index; CutoffEM: cutoff defined by the Expectation-Maximization algorithm; CutoffNC: cutoff calculated as mean + 3*standard deviations of the log10-transformed MFI levels from the non-endemic population. The rest of the antigens are in Fig 8.
(DOCX)
Data Availability Statement
Data cannot be shared publicly because of participants consent restrains. However, data will be available on a reasonable request to the external data management unit in ISGlobal (ubioesdm@isglobal.es).










